Grape seed proanthocyanidins ameliorate diabetic nephropathy via modulation of levels of AGE, RAGE and CTGF.

Li, Xianhua; Xiao, Yunling; Gao, Haiqing; Li, Baoying; Xu, Ling; Cheng, Mei; Jiang, Bei; Ma, Yabing

Li, Xianhua; Xiao, Yunling; Gao, Haiqing; Li, Baoying; Xu, Ling; Cheng, Mei; Jiang, Bei; Ma, Yabing.

Affiliation

Li X; Department of Nephrology, Qi Lu Hospital of Shandong University, Jinan, PR China.

Nephron Exp Nephrol ; 111(2): e31-41, 2009.

Article in En | MEDLINE | ID: mdl-19142024

Subject(s)

Connective Tissue Growth Factor/physiology; Diabetic Nephropathies/drug therapy; Diabetic Nephropathies/metabolism; Glycation End Products, Advanced/physiology; Grape Seed Extract/therapeutic use; Proanthocyanidins/therapeutic use; Receptors, Immunologic/physiology; Animals; Diabetic Nephropathies/pathology; Grape Seed Extract/pharmacology; Male; Proanthocyanidins/pharmacology; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Plantas_medicinales Main subject: Receptors, Immunologic / Glycation End Products, Advanced / Proanthocyanidins / Diabetic Nephropathies / Connective Tissue Growth Factor / Grape Seed Extract Language: En Journal: Nephron Exp Nephrol Year: 2009 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google